4.8 Article

Right Cu2-xS@MnS Core-Shell Nanoparticles as a Photo/H2O2-Responsive Platform for Effective Cancer Theranostics

期刊

ADVANCED SCIENCE
卷 6, 期 20, 页码 -

出版社

WILEY
DOI: 10.1002/advs.201901461

关键词

cancer treatment; Cu2-xS@MnS; patient-derived xenografts; photo/H2O2-responsive platforms; tumor cell line-derived xenografts

资金

  1. National Natural Science Foundation of China [81572656, 8187219, 51972055]
  2. National Key Research and Development Program of China [2017YFC0908500]
  3. Shenzhen Science and Technology Research Project [JCYJ20180508152903208]
  4. Shenzhen Pengcheng Scholar Program

向作者/读者索取更多资源

Stimuli-responsive nanomedicines have become a recent research focus as a candidate for cancer treatment because of their effectiveness, sensibility, and minimal invasiveness. In this work, a novel nanosystem is developed based on Cu2-xS@MnS core-shell nanoparticles (CSNPs) in which the Cu2-xS core serves as a photosensitizer to generate hyperthermia and reactive oxygen species (ROS), and the MnS shell is used in H2O2-responsive O-2 production. Cu2-xS@MnS CSNPs with an independent core and shell ratio are synthesized by a controllable hot-injection method, resulting in an optimal photothermal (PT) effect with a PT conversion efficiency of up to 47.9%. An enhanced photodynamic (PD) effect also occurs in an H2O2 environment. More significantly, in vivo experiments demonstrate that Cu2-xS@MnS CSNPs can mediate tumor shrinkage in both HeLa tumor cell line-derived xenograft (CDX) and head and neck squamous cell carcinoma (HNSCC) patient-derived xenograft (PDX) models, with the capability of being used as a T1-enhanced magnetic resonance (MR) contrast agent. These results suggest the great potential of as-prepared Cu2-xS@MnS CSNPs as photo/H2O2-responsive therapeutic-agents against tumors, even in a complicated and heterogeneous environment, thus promoting the clinical translation of nanomedicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据